-
Use of an Independent Data Review Committee to Promote Best Practices for External Control Arms: A Case Study in Relapsed/Refractory Multiple Myeloma
Mar 10, 2025, 14:00 PM -
Strategic Implications of EU HTAR (JCA and JSC) for Global Biopharma and Biotechs: Navigating Evolving Paradigms in Market Access
Mar 10, 2025, 14:00 PM -
The Clinical Impact of Discontinuation of Sodium-Glucose Transport Protein 2 Inhibitors (SGLT2is): A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Are Patients With Major Depressive Disorder (MDD) Getting Access to Innovation in HTA Markets? Review of Reimbursement Decisions of Pharmacotherapies for MDD in Europe, Australia, and Canada From 2001 to 2021
Mar 10, 2025, 14:00 PM -
Impact of Capacity and Resource Constraints on Wet Age-Related Macular Degeneration and Diabetic Macular Edema in the Brazilian Public Healthcare System: an Individual-Level Microsimulation Study
Mar 10, 2025, 14:00 PM -
Natural History and Burden of Disease Among Patients With Juvenile GM2 Gangliosidoses in France
Mar 10, 2025, 14:00 PM -
Daily Intravenous Ketamine for Treatment-Resistant Depression: a Cost-Effectiveness Analysis Alongside the Clinical Trail
Mar 10, 2025, 14:00 PM -
Racial/Ethnic Disparities in Pneumococcal Vaccination Rates Among the Elderly: Trends and Associated Factors in the U.S., 2018-2023
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Technological Innovation for Chronic Wounds: Pharmacoeconomic Model Based on LOGIT and MAIC Tools
Mar 10, 2025, 14:00 PM -
Who Benefits From Technological Progress Among People With Type 1 Diabetes? Improvements in Glycemic Outcomes After CGM Adoption by Sociodemographic Characteristics
Mar 10, 2025, 14:00 PM -
Geographic Inequities in Bariatric Surgery Access in Southern Chile: The Case of the Chilean Bundled Payment PAD
Mar 10, 2025, 14:00 PM -
Cost Per Responder Analysis of Patients With 3 Previous Lines and Lenalidomide Refractory Multiple Myeloma Who Received Cilta-Cel in the Brazilian Private Health System
Mar 10, 2025, 14:00 PM -
Identifying Treatment Patterns for Essential Thrombocythemia Using Real-world Data
Mar 10, 2025, 14:00 PM -
Drivers of Variability Exploration (DiVE!): A Review to Inform a Proposed Observational Study Evidence Synthesis and Reporting Checklist
Mar 10, 2025, 14:00 PM -
Balancing Baseline Characteristics With SMOTE and Propensity Score Weighting in a Comparative Study of PASCAL Transcatheter Valve Repair and Medical Therapy for Degenerative Mitral Regurgitation
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patients from the Integra Connect Database
Mar 10, 2025, 14:00 PM -
Advancing Real World Evidence: Comparative Insights into Global Practices and China's Strategic Progress
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Smart Infusion Pumps With Dedicated Equipment vs. Pumps With Basic Programming in Infusion Therapy in ICU
Mar 10, 2025, 14:00 PM -
Inequities in Access to Oncology Drugs in Brazil - the Case of Public and Private Healthcare Systems
Mar 10, 2025, 14:00 PM -
What Proportion of the Total Value Generated by New Drugs Accrues to Manufacturers? A Review of Empirical Estimates of Producer Surplus
Mar 10, 2025, 14:00 PM
